194 related articles for article (PubMed ID: 2064350)
1. Classic prognostic factors, flow cytometric data, nuclear morphometric variables and mitotic indexes as predictors in transitional cell bladder cancer.
Lipponen PK; Eskelinen MJ; Kiviranta J; Nordling S
Anticancer Res; 1991; 11(2):911-6. PubMed ID: 2064350
[TBL] [Abstract][Full Text] [Related]
2. Nuclear morphometry in grading transitional cell bladder cancer compared with subjective histological grading.
Lipponen P; Eskelinen M
Anticancer Res; 1990; 10(6):1725-30. PubMed ID: 2285249
[TBL] [Abstract][Full Text] [Related]
3. Stereologically measured nuclear volume in comparison to two-dimensional nuclear morphometry, mitotic index and flow cytometry in predicting disease outcome in bladder cancer.
Lipponen PK
Anticancer Res; 1993; 13(2):529-32. PubMed ID: 8517668
[TBL] [Abstract][Full Text] [Related]
4. Nuclear morphometry and mitotic indexes as prognostic factors in breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Alhava E; Syrjänen K
Eur J Surg; 1991 May; 157(5):319-24. PubMed ID: 1678644
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis.
Lipponen PK; Aaltomaa S
J Pathol; 1994 Aug; 173(4):333-9. PubMed ID: 7965393
[TBL] [Abstract][Full Text] [Related]
6. How to count mitoses in bladder cancer grading?
Lipponen PK; Eskelinen MJ
Anticancer Res; 1991; 11(2):825-9. PubMed ID: 2064337
[TBL] [Abstract][Full Text] [Related]
7. DNA ploidy, S-phase fraction and mitotic indices as prognostic predictors of female breast cancer.
Lipponen P; Papinaho S; Eskelinen M; Klemi PJ; Aaltomaa S; Kosma VM; Marin S; Syrjänen K
Anticancer Res; 1992; 12(5):1533-8. PubMed ID: 1444217
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of DNA content in bladder cancer based on flow cytometric analysis of 249 transitional cell carcinomas.
Vindeløv LL; Christensen IJ; Engelholm SA; Guldhammer BH; Højgaard K; Sørensen BL; Wolf H
Cytometry; 1995 Jun; 22(2):93-102. PubMed ID: 7587754
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of transitional cell bladder cancer: a multivariate prognostic score for improved prediction.
Lipponen PK; Eskelinen MJ; Kiviranta J; Pesonen E
J Urol; 1991 Dec; 146(6):1535-40. PubMed ID: 1942335
[TBL] [Abstract][Full Text] [Related]
10. Comparison of classic and quantitative prognostic factors in colorectal cancer.
Ropponen K; Eskelinen M; Kosma VM; Lipponen P; Paakkinen P; Alhava E
Anticancer Res; 1996; 16(6B):3875-82. PubMed ID: 9042274
[TBL] [Abstract][Full Text] [Related]
11. Independent prognostic factors in T2/T3 transitional cell bladder tumours with special reference to histoquantitative methods.
Lipponen PK; Eskelinen MJ; Jauhiainen K; Terho R; Nordling S
Surg Oncol; 1992 Apr; 1(2):135-43. PubMed ID: 1341244
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer in young women: clinical, histological and morphometric prognostic factors.
Eskelinen M; Lipponen P; Aaltomaa S; Kosma VM; Syrjänen K; Alhava E
Anticancer Res; 1992; 12(4):1237-42. PubMed ID: 1503415
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
14. Proliferation indices as independent prognostic factors in papillary Ta-T1 transitional cell bladder tumours.
Lipponen PK; Eskelinen MJ; Jauhiainen K; Terho R; Nordling S
Br J Urol; 1993 Oct; 72(4):451-7. PubMed ID: 8261303
[TBL] [Abstract][Full Text] [Related]
15. Image analysis of Ag-NOR proteins in transitional cell bladder cancer.
Lipponen P
J Pathol; 1993 Dec; 171(4):279-83. PubMed ID: 8158457
[TBL] [Abstract][Full Text] [Related]
16. Independent clinical, histological and quantitative prognostic factors in transitional-cell bladder tumours, with special reference to mitotic frequency.
Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho R; Haapasalo H
Int J Cancer; 1992 May; 51(3):396-403. PubMed ID: 1592531
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters.
Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Requena MJ; Montironi R
Am J Clin Pathol; 2004 Sep; 122(3):444-52. PubMed ID: 15362377
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of cell deoxyribonucleic acid content measured by flow cytometry in bladder cancer.
Bittard H; Lamy B; Billery C
J Urol; 1996 Jun; 155(6):1887-91. PubMed ID: 8618280
[TBL] [Abstract][Full Text] [Related]
19. p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder.
Casetta G; Gontero P; Russo R; Pacchioni D; Tizzani A
Eur Urol; 1997; 32(2):229-36. PubMed ID: 9286659
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumours and their relation to prognosis during a long-term follow-up.
Lipponen P; Aaltoma S; Kosma VM; Ala-Opas M; Eskelinen M
J Pathol; 1998 Oct; 186(2):157-64. PubMed ID: 9924431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
